The Colton Center for Autoimmunity, University of Pennsylvania
@penncoltoncenter.bsky.social
200 followers 490 following 12 posts
Our mission is to apply bold, collaborative, translational science to advance our mechanistic understanding of human autoimmunity. Proudly part of the @coltonconsortium.bsky.social‬. Learn more: www.med.upenn.edu/penncoltoncenterautoimmunity
Posts Media Videos Starter Packs
penncoltoncenter.bsky.social
Last week, Dr. Wherry showed Good Morning Philadelphia around Penn Medicine's new collaborative research hub for #immunology, #immunehealth, and #autoimmunity, including the new home of the Penn Colton Center for Autoimmunity. Watch the interview: https://www.fox29.com/video/1707836
Penn Medicine Opens $376M Immunology Center Boosting Research in Philadelphia
New Penn Medicine center houses hundreds of researchers testing treatments for autoimmune conditions.
www.fox29.com
penncoltoncenter.bsky.social
Have you registered yet for next week's session (9/16, 11AM ET) of the #ColtonConsortium Virtual Speaker Series featuring Mark Anderson, MD, PhD (USCF + @ucsfdc.bsky.social)? Dr. Anderson will address "Dissection of #Autoimmunity Through Outliers." Registration required: bit.ly/AndersonSept16
Colton Consortium Virtual Speaker Series. Dissection of Autoimmunity Through Outliers. Mark Anderson, MD, PhD. Sept. 16, 2025 (11AM ET). QR code to register.
penncoltoncenter.bsky.social
We're thrilled to share space in Penn Medicine's new collaborative research hub for #immunology, #immunehealth, and #autoimmunity — working with remarkable labs and leaders to advance scientific breakthroughs that benefit patients' lives.
i3h-upenn.bsky.social
Last week, Penn Medicine leaders cut the ribbon on a new home for #immunology research. The eight-story "overbuild" at 3600 Civic Center Blvd will house I3H, #ImmuneHealth, @penncoltoncenter.bsky.social, and related areas to foster interdisciplinary collaboration.

▶️ Watch: youtu.be/Ryv2AxPtb_E?...
Building Upon Excellence: Penn’s New Collaborative Research Hub
YouTube video by Penn Medicine
youtu.be
penncoltoncenter.bsky.social
Katalin Susztak, MD, PhD, and team developed #AI tools and datasets—like the SISKA atlas and CellSpectra—to map 70+ kidney cell types. This advances precision medicine with the potential to reveal new insights into immune-mediated kidney disease. bit.ly/4mSH0lk
Penn-developed AI tools and datasets help tailor treatments for kidney patients | Penn Today
Penn Medicine and Wharton researchers have partnered to create CellSpectra and SISKA, offering clues to better treatments for kidney disease and beyond.
bit.ly
penncoltoncenter.bsky.social
Don't miss the next installment (9/16, 11AM ET) of the #ColtonConsortium Virtual Speaker Series featuring Mark Anderson, MD, PhD (UCSF + @ucsfdc.bsky.social), a leader in #diabetes and #autoimmunity research. Registration required: bit.ly/AndersonSept16
Colton Consortium Virtual Speaker Series. Mark Anderson, MD, PhD, Robert Friend and Michelle M. Friend Endowed Chair in Diabetes Research, University of California, San Francisco. September 16, 2025, 11:00 AM ET. Registration required [QR code].
penncoltoncenter.bsky.social
coltonconsortium.bsky.social
The 2025 Colton Consortium Symposium brought together leaders, researchers, and partners from Penn, NYU, Yale, and Tel Aviv University to share their scientific breakthroughs and plan the next advances in autoimmune disease research.

🔎 Check out our recap: www.coltonconsortium.org/blog/inside-...
A smiling symposium attendee holds a microphone during an audience Q&A session.
penncoltoncenter.bsky.social
Earlier this year, the Colton Center for Autoimmunity at @pennmedicine.bsky.social launched two new Centers of Excellence to advance autoimmune diagnostics and treatment—deepening its impact through the @coltonconsortium.bsky.social. Learn more about the missions of HIT-AI and CREATE: bit.ly/4kRTJCT
Colton Center for Autoimmunity Consortium - Main
bit.ly
penncoltoncenter.bsky.social
Congratulations to Sahily Reyes-Esteves, MD, PhD (@sahilyreyes.bsky.social), Assistant Professor of Neurology and Colton Center awardee, and our other Penn Medicine (@pennmedicine.bsky.social) colleagues on being selected for a McCabe Fund Award! 🏆
pennmedcso.bsky.social
Congratulations to this year's @pennmedicine.bsky.social McCabe Fund Awardees! @PennRheum @PennRadOnc @PennRadiology #Dermatology @pennsurgery.bsky.social @PennNeurology @Penn_DFMCH @PennPulmonary @dbei-upenn.bsky.social @chopresearch.bsky.social @PennVet tinyurl.com/546y5nmc
penncoltoncenter.bsky.social
Genetic screening may have unlocked a path for treating the severe inflammation associated with many immune diseases by regulating one protein’s role in helping another protein control cell acidity, according to recent research published in Cell by the @minerlab.bsky.social. bit.ly/43Hw6HK
Controlling cell acidity could be key to autoimmune disease | Penn Medicine
Genetic screening may have unlocked a path for treating severe inflammation in autoimmune disease by regulating proteins controlling cell acidity.
www.pennmedicine.org
penncoltoncenter.bsky.social
Big news out of @pennmedicine.bsky.social: @davidfajgenbaum.bsky.social, @jbrandmdphd.bsky.social, and colleagues have identified Oligocentric Castleman Disease (OligoCD)—the first new Castleman subtype in 45 years. This discovery has the potential to reshape diagnosis and care for thousands.
pennmedcso.bsky.social
For the first time in 45 years, a new subtype of Castleman disease has been identified, allowing patients to receive the right treatment for their condition ft. @davidfajgenbaum.bsky.social (@pennmedicine.bsky.social) & @jbrandmdphd.bsky.social (@penncancer.bsky.social) tinyurl.com/52mjd9az
penncoltoncenter.bsky.social
i3h-upenn.bsky.social
Congrats @davidfajgenbaum.bsky.social on being named to the TIME100 Health 2025 list! After being diagnosed with Castleman disease, he found an existing drug that saved his life. Now he’s using AI to repurpose FDA-approved drugs—offering hope to others with hard-to-treat conditions. bit.ly/4kdkgdX
TIME100 Health: David Fajgenbaum
Find out why David Fajgenbaum is on the TIME100 Health 2025 list.
bit.ly
penncoltoncenter.bsky.social
150+ experts came together at the 2025 Penn Colton Center for #Autoimmunity Symposium to discuss breakthroughs in #ImmuneHealth and spotlight Penn’s leadership, future headquarters, and innovations in autoimmunity research and #PrecisionMedicine.

Read more: www.coltonconsortium.org/blog/2025-pe...
A large group of Penn Colton Center for Autoimmunity members pose in front of a statue of Benjamin Franklin inside the Franklin Institute in Philadelphia, PA.